skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

35 Total results for product and free and sample content found

Pink Sheet

The Tricky Task Of Bringing Smaller EU Countries Into The Fold

By Maureen ​ Kenny 12 Sep 2018

Clusters of excellence, competition as well as co-operation, Brexit, and aiming high. Danish Medicines Agency head Thomas Senderovitz talks national agencies and engagement in an interview with the Pink Sheet.

Topic Brexit Drug development landscape Drug approval

Pink Sheet

Brexit Likely To Force Refocusing Of Ambitious EU Network Strategy

By Maureen ​ Kenny 12 Sep 2018

The European Medicines Agency and drug regulators throughout the EU are having to invest huge amounts of time and effort in dealing with the fall-out from Brexit - and it hasn't even happened yet. Plans for working together on bigger issues agreed on a few years ago will likely have to change, senior regulator Thomas Senderovitz tells the Pink Sheet.

Topic Brexit Business strategies

Pink Sheet

Big Data In Medicines Regulation Will Need ‘Considerable Change In Mindset’

By Maureen ​ Kenny 12 Sep 2018

Changing mindsets, technologies outpacing regulatory frameworks, intense international collaboration, and the future of the randomized controlled clinical trial. Big data is forcing us to think big, senior European regulator Thomas Senderovitz tells the Pink Sheet.

Topic Brexit Business strategies

Medtech Insight

Notified Body Capacity: TEAM-NB Members Way Ahead But Picture Clouded By Brexit

By Amanda Maxwell 30 Aug 2018

With the pressure increasing on manufacturers to have their products reassessed under the current EU medical devices directives or under the new EU regulations, where can capacity be found?

Topic Brexit Business strategies

Scrip

Sanofi Top UK Exec Plans For Hard Brexit, Blasts 'Poor Access' To New Drugs

By Sten Stovall 22 Aug 2018

The managing director for Sanofi in the UK says clinical trials there will become less likely in future if access to innovative drugs doesn't improve, causing comparative standards of care to deteriorate.

Topic Brexit Business strategies Clinical trials

Scrip

Pharma Backs UK Parliament Report As 'No Deal Brexit' Fears Grow

22 Aug 2018

The pharmaceutical sector has given its backing to a report from MPs which warns that a no-deal Brexit will have a hugely damaging effect on the industry in the country, turning it into "a second-tier state for new and innovative medicines."

Topic Brexit Business strategies

Medtech Insight

New Reasons Not To Use EU MDR's Four-Year Extension, But Comply Earlier Or Retire Products Instead

By Amanda Maxwell 22 Aug 2018

The new EU Medical Device Regulation offers companies an option to market CE-marked devices for an extra four years under current directives. But more hurdles are being identified that make this option less attractive.

Topic Brexit Business strategies

Pink Sheet

Long-Awaited Brexit White Paper Lays Out UK's Plans For Medicines Regulation

By Francesca Bruce 22 Aug 2018

The UK government has finally published its white paper on the UK’s future relationship with the EU following Brexit, to the relief of the pharmaceutical industry.

Topic Brexit

Scrip

Pre-Brexit: UK Biotechs Still Dominate European Fundraising

25 Jul 2018

Using data provided by Informa Pharma Intelligence, the UK BioIndustry Association reports that UK biotechs continue to take the lion's share of European fundraising. 

Topic Brexit

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: